Skip to Main Content

Erin Hofstatter, MD

Associate Professor Adjunct
DownloadHi-Res Photo

About

Titles

Associate Professor Adjunct

Biography

Dr. Erin Hofstatter is a medical oncologist with clinical and research expertise in breast cancer and clinical breast cancer genetics. Dr. Hofstatter consults with patients in the Breast Cancer Prevention Clinic, where she sees patients who may be at increased risk of breast cancer due to a hereditary/genetic predisposition and/or a strong family history.

Appointments

Other Departments & Organizations

Education & Training

Fellow
Beth Israel Deaconess Medical Center (2010)
Participant
Harvard School of Public Health (2009)
Chief Resident
Mount Auburn Hospital (2007)
Resident
Mount Auburn Hospital (2006)
Intern
Mount Auburn Hospital (2004)
MD
University of Connecticut School of Medicine (2003)
BA
Amherst College, Biology (1997)

Research

Overview

Dr. Hofstatter serves as an academic breast cancer medical oncologist and Co-Director of the Smilow Cancer Genetics and Prevention Program at Yale, with a clinical specialty and research interest in breast cancer risk. Her clinical work includes seeing patients with breast cancer as well as patients at high risk of breast cancer due to a genetic mutation or other strong risk profile. Thus, her clinical work directly informs and inspires her research in breast cancer treatment and prevention. Since taking on the role of Co-Director of the Cancer Genetics and Prevention Program in 2014, she has successfully grown the clinical genetic counseling service to serve over 2000 patients per year, at multiple sites throughout the state of Connecticut. She has developed a robust clinical program that blends the services of genetic counselors and physicians, and has built a collaborative research program including a rich biorepository. In addition, Dr. Hofstatter serves as the Principal Investigator of several national cooperative group trials, including several trials for BRCA+ breast cancer, as well as her own investigator-initiated trials in DCIS and triple-negative breast cancer. She has developed skills in clinical trial design, survey development, epidemiology and biostatistics through her training and academic practice. Furthermore, Dr. Hofstatter has also developed skills in translational research, serving as Principal Investigator on a study examining epigenetic signatures of breast cancer risk and measures of aging in normal breast tissue.clinical breast cancer genetics

Medical Subject Headings (MeSH)

Breast Neoplasms

Research at a Glance

Yale Co-Authors

Frequent collaborators of Erin Hofstatter's published research.

Publications

2024

2022

2021

2020

2019

2018

Academic Achievements & Community Involvement

  • activity

    University of Wisconsin Health Experiences USA/Breast Cancer Advisory Panel

  • activity

    Cancer, PLOS1, Maturitas, UpToDate, British Journal of Cancer, Breast Cancer Research, Annals of Oncology, JAMA Oncology, Frontiers in Surgery, JCO Clinical Cancer Informatics

  • activity

    Caribbean Alliance to Control and Prevent Cancer 2021 Meeting

  • activity

    Boy Scouts of America

  • activity

    ASCO Cancer Prevention Scientific Program Committee

Get In Touch

Contacts

Appointment Number
Clinic Fax Number